ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc.
Saved in:
| Title: | ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc. |
|---|---|
| Authors: | Cheng, Yuanyuan1 (AUTHOR) chengwang0915@163.com, Lin, Lishuang1 (AUTHOR), Li, Xiaoyan2 (AUTHOR), Lu, Aiqi1 (AUTHOR), Hou, Chenjian3 (AUTHOR), Wu, Qian1 (AUTHOR), Hu, Xiaomu1 (AUTHOR), Zhou, Zhongwen1 (AUTHOR), Chen, Zhongqing1 (AUTHOR), Tang, Feng1 (AUTHOR) |
| Source: | Cancer Cell International. 1/7/2021, Vol. 21 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
